The need to know
EFT
JULY 22, 2025
by 2030, it said on Monday, the latest big investment by a pharmaceutical company reacting to President Donald Trump's tariff policy. AstraZeneca unveils $50 billion US investment as pharma tariff threat looms AstraZeneca (AZN.L) plans to spend $50 billion to expand manufacturing and research capabilities in the U.S.
Let's personalize your content